Answers are grounded in this paper and cite their sources.
Immunotherapy has evolved and has revolutionized clinical oncology in recent years, achieving unprecedented clinical responses and outcomes. Precision medicine has the specific goal to treat the disease while limiting the damages derived from treatments. For that reason, it is important for radiologists to understand treatment response to immunotherapy, as development and approval of immunotherapeutics is increasing steadily. This article aims to educate radiologists on the mechanisms, benefits, and pitfalls of assessing immunotherapy response with molecular imaging.
No takes yet. Share an insight, caveat, or question.
Varney et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: